Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion type Assertion NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_head.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion evidence source_evidence_literature NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion SIO_000772 22297444 NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion wasDerivedFrom befree-20150227 NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion wasGeneratedBy ECO_0000203 NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.